Locanabio expects to submit IND application in mid-2024 for first program, LBIO-115, designed to promote…
Locanabio expects to submit IND application in mid-2024 for first program, LBIO-115, designed to promote…
Expanded indication for ZORYVE provides new, steroid-free topical for children 6 to 11 with plaque…
Expanded indication for ZORYVE provides new, steroid-free topical for children 6 to 11 with plaque…
California cannabis leader repurchases all outstanding senior secured convertible indebtedness SALINAS, Calif., Oct. 06, 2023…
California cannabis leader repurchases all outstanding senior secured convertible indebtedness SALINAS, Calif., Oct. 06, 2023…
BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) — LSL Pharma Group Inc. (TSXV: LSL) –…
BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) — LSL Pharma Group Inc. (TSXV: LSL) –…
Immunocore announces upcoming presentation and posters at ESMO 2023 Long-term survival data for KIMMTRAK in…
MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the…
LONDON, Oct. 06, 2023 (GLOBE NEWSWIRE) — With Google introducing Android 14 a few days…
Sensei Labs’ partnership with Tata Consultancy Services Helps Enterprises Orchestrate Their Most Critical Transformations and…
Toronto, Ontario–(Newsfile Corp. – October 6, 2023) – Wellfield Technologies Inc. (TSXV: WFLD) (OTCQB: WFLDF)…
KUCHING, MALAYSIA, Oct 6, 2023 – (ACN Newswire) – At the 27th World Congress on…
SINGAPORE, Oct 6, 2023 – (ACN Newswire) – PT Bank Tabungan Negara (Persero) Tbk (“Bank…
DUBAI, United Arab Emirates–(BUSINESS WIRE)–MultiBank Group, the global finance and technology giant, announced a record-breaking…
ORLANDO, Fla.–(BUSINESS WIRE)–Laser Photonics Corporation, a leading global developer of industrial laser systems for laser…
Institutional planning drives DMI higher, while commercial planning declines HAMILTON, N.J.–(BUSINESS WIRE)–The Dodge Momentum Index…
SAN FRANCISCO–(BUSINESS WIRE)–Wells Fargo & Company (NYSE: WFC), as previously announced, will report its third…
Type II Extension of Indication Application is supported by data from PAPILLON, the first randomised…